BRIEF published on 09/25/2026 at 18:05, 1 month 10 days ago ABIVAX : Informations sur le capital social et les droits de vote au 31 août 2026 Euronext Paris Droits De Vote Capital Social Abivax Marchés Financiers
PRESS RELEASE published on 09/25/2026 at 18:00, 1 month 10 days ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26 ABIVAX annonce le nombre d'actions et de droits de vote au 31.08.26. Ofebazimod en phase 3 pour la rectocolite hémorragique. Informations réglementaires disponibles Droits De Vote Actions Abivax Rectocolite Hémorragique Ofebazimod
BRIEF published on 09/25/2026 at 11:41, 1 month 10 days ago BlackRock crosses thresholds in ABIVAX's capital Voting Rights Abivax BlackRock Crossing Thresholds Transfer Of Shares
BRIEF published on 09/25/2026 at 11:41, 1 month 10 days ago Franchissement de seuils par BlackRock dans le capital d'ABIVAX Droits De Vote Abivax Franchissement De Seuils BlackRock Cession D'actions
PRESS RELEASE published on 09/25/2026 at 11:36, 1 month 10 days ago Franchissement de seuils Déclaration de franchissement de seuils par BlackRock, Inc. pour la société ABIVAX le 22 septembre 2026 Déclaration AMF Abivax Franchissement De Seuils BlackRock
BRIEF published on 09/22/2026 at 10:43, 1 month 13 days ago BlackRock dépasse 5% du capital d'ABIVAX Euronext Paris Franchissement De Seuil Abivax BlackRock Capital Et Droits De Vote
BRIEF published on 09/22/2026 at 10:43, 1 month 13 days ago BlackRock exceeds 5% of ABIVAX's capital Euronext Paris Abivax BlackRock Threshold Crossing Capital And Voting Rights
PRESS RELEASE published on 09/22/2026 at 10:38, 1 month 13 days ago Franchissement de seuils Déclaration de franchissement de seuils par la société BlackRock, Inc. pour le compte de clients et de fonds de la société ABIVAX Capital Déclaration Abivax Franchissement De Seuils BlackRock
BRIEF published on 09/21/2026 at 22:10, 1 month 14 days ago Abivax Reports Business Updates and First Half 2026 Financial Results Financial Results Biotechnology Leadership Changes Abivax Obefazimod
BRIEF published on 09/21/2026 at 22:10, 1 month 14 days ago Abivax publie ses dernières informations et ses résultats financiers du premier semestre 2026 Résultats Financiers Biotechnologie Abivax Obefazimod Changements De Direction
Published on 11/05/2026 at 23:55, 40 minutes ago Santé Canada autorise deux vaccins à ARNm de Moderna : un vaccin contre la grippe et un vaccin combiné contre la grippe et la COVID-19
Published on 11/05/2026 at 23:20, 1 hour 15 minutes ago Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines
Published on 11/05/2026 at 22:05, 2 hours 30 minutes ago Innodata Reports Record Third Quarter 2026 Results
Published on 11/05/2026 at 22:01, 2 hours 34 minutes ago Unusual Machines Third Quarter 2026 Shareholder Letter
Published on 11/05/2026 at 15:20, 9 hours 15 minutes ago MicroVision and LAKE FUSION Technologies Sign Multi-Year Strategic Partnership Agreement for IRIS(TM) Lidar Sensors
Published on 11/06/2026 at 00:05, 30 minutes ago RBI: Announcement of the result of the voluntary public tender offer for all Addiko shares following expiration of the grace period
Published on 11/05/2026 at 22:05, 2 hours 30 minutes ago Quantinuum Reports Third Quarter 2026 Results and Raises Full-Year Revenue Outlook
Published on 11/05/2026 at 20:38, 3 hours 57 minutes ago freenet uses funds from Ceconomy sale for waipu.tv acquisition and share buyback
Published on 11/05/2026 at 20:37, 3 hours 58 minutes ago EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 75 million
Published on 11/05/2026 at 19:45, 4 hours 49 minutes ago Stabilus SE fulfills forecast for fiscal 2026 and adjusts 2030 medium-term targets
Published on 11/05/2026 at 18:21, 6 hours 13 minutes ago Capital et droits de vote au 31 octobre 2026
Published on 11/05/2026 at 18:21, 6 hours 13 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026
